Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-05-23T17:23:31.976Z Has data issue: false hasContentIssue false
  • English
  • Français

First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate

Published online by Cambridge University Press:  02 June 2010

Goetz Christoph Mueller ,
Ali Dodge-Khatami  and
Jochen Weil
Goetz Christoph Mueller*
Affiliation:
Department of Paediatric Cardiology, University Heart Center Hamburg, Hamburg, Germany
Ali Dodge-Khatami
Affiliation:
Department of Congenital Cardiac Surgery, University Heart Center Hamburg, Hamburg, Germany
Jochen Weil
Affiliation:
Department of Paediatric Cardiology, University Heart Center Hamburg, Hamburg, Germany
*
Correspondence to: G. C. Mueller, MD, Department of Paediatric Cardiology, University Heart Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg/Germany. Tel: +49 (0)40 7410-53718; Fax: +49 (0)40 7410-53730; E-mail: go.mueller@uke.uni-hamburg.de
Get access Rights & Permissions [Opens in a new window]

Abstract

Paclitaxel-eluting balloons are a new and innovative method in the treatment of in-stent stenosis and small vessel disease in adult cardiac pathology. The treatment of congenital pulmonary vein stenosis is difficult to manage, and results in a high mortality rate due to residual or recurrent stenosis. We report the first case of treatment for neonatal pulmonary vein restenosis with a paclitaxel-eluting balloon.

Keywords

Pulmonary vein stenosisdrug-eluting balloonpaclitaxelcongenital cardiac diseaseintervention
Type
Brief Reports
Information
Cardiology in the Young , Volume 20 , Issue 4 , August 2010 , pp. 455 - 458
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Latson, LA, Prieto, LR. Congenital and acquired pulmonary vein stenosis. Circulation 2007; 115: 103–108.CrossRefGoogle ScholarPubMed
2. Breinholt, JP, Hawkins, JA, Minich, LA, et al. . Pulmonary vein stenosis with normal connection: associated cardiac abnormalities and variable outcome. Ann Thorac Surg 1999; 68: 164–168.CrossRefGoogle ScholarPubMed
3. Driscoll, DJ, Hesslein, PS, Mullins, CE. Congenital stenosis of individual pulmonary veins: clinical spectrum and unsuccessful treatment by transvenous balloon dilation. Am J Cardiol 1982; 49: 1767–1772.CrossRefGoogle ScholarPubMed
4. Seale, AN, Daubeney, PE, Magee, AG, Rigby, ML. Pulmonary vein stenosis: initial experience with cutting balloon angioplasty. Heart 2006; 92: 815–820.CrossRefGoogle ScholarPubMed
5. Tomita, H, Watanabe, K, Yazaki, S, et al. . Stent implantation and subsequent dilatation for pulmonary vein stenosis in pediatric patients: maximizing effectiveness. Circ J 2003; 67: 187–190.CrossRefGoogle ScholarPubMed
6. Herdeg, C, Oberhoff, M, Baumbach, A, et al. . Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol 2000; 35: 1969–1976.CrossRefGoogle ScholarPubMed
7. Scheller, B, Speck, U, Bohm, M. Prevention of restenosis: is angioplasty the answer? Heart 2007; 93: 539–541.CrossRefGoogle ScholarPubMed
8. Scheller, B, Speck, U, Romeike, B, et al. . Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J 2003; 24: 1462–1467.CrossRefGoogle ScholarPubMed
9. Huizing, MT, Keung, AC, Rosing, H, et al. . Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. J Clin Oncol 1993; 11: 2127–2135.CrossRefGoogle Scholar
10. Sadr, IM, Tan, PE, Kieran, MW, Jenkins, KJ. Mechanism of pulmonary vein stenosis in infants with normally connected veins. Am J Cardiol 2000; 86: 577–579.CrossRefGoogle ScholarPubMed